companies / nushores-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-08 json
| total_raised | 3,000,0003.0M | ○ |
|---|---|---|
| founded | 2014 | |
| hq | LITTLE ROCK, Arkansas | |
| industry | unknown | |
| stage | null |
NuShores Biosciences makes NuCress, regenerative scaffolds engineered to heal large segmental bone defects above 2.5 cm across cranio-maxillofacial, dental, spinal, and limb injuries. Customers are surgeons and orthopaedic groups treating trauma, oncology, and military bone-loss cases. The scaffolds have been tested in nearly 500 large-animal subjects with minimal infection or rejection.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | grant | 3,000,0003.0M | null | ○ |
Nginx 1.25.5, PHP, Layers, Slider Revolution, jQuery Migrate 3.4.1, Endurance Page Cache, parallax.js, prettyPhoto, Contact Form 7 6.1.6, Open-Xchange App Suite, Bluehost, Boost.ai
| fact | status | src |
|---|---|---|
| Grant, $3.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |